The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

IX.f

Hiccup

Publications

Tazi I, Zaoui S, Nafil H, Mahmal L

[Hiccups ad severe hyponatremia induced by low dose cyclophosphamide therapy for Burkitt lymphoma].

Annales de biologie clinique. 2011;69(5):613-4

Lazarevic V, Hägg E, Wahlin A

Hiccups and severe hyponatremia associated with high-dose cyclophosphamide in conditioning regimen for allogeneic stem cell transplantation.

American journal of hematology. 2007;82(1):88

Ifran A, Kaptan K, Beyan C

Intractable hiccups may develop with cyclophosphamide infusion.

American journal of hematology. 2004;77(3):319-20

Kanwar AJ, Kaur S, Dhar S, Ghosh S

Hiccup--a side-effect of pulse therapy.

Dermatology (Basel, Switzerland). 1993;187(4):279